SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-001623
Filing Date
2022-01-05
Accepted
2022-01-05 16:02:19
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6131
  Complete submission text file 0001209191-22-001623.txt   7434
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Issuer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address
Edwards Martin (Reporting) CIK: 0001640073 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37785 | Film No.: 22511056